CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 129 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $47,238 | -55.4% | 17,692 | -27.6% | 0.00% | -100.0% |
Q4 2021 | $105,851 | +110.5% | 24,446 | +147.4% | 0.00% | – |
Q3 2021 | $50,289 | -69.6% | 9,880 | -62.2% | 0.00% | -100.0% |
Q2 2021 | $165,264 | +306.3% | 26,108 | +396.2% | 0.00% | – |
Q1 2021 | $40,675 | -58.7% | 5,262 | -65.0% | 0.00% | -100.0% |
Q4 2020 | $98,420 | -1.5% | 15,026 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $99,923 | -56.1% | 15,026 | -45.0% | 0.00% | -66.7% |
Q2 2020 | $227,426 | +8.6% | 27,302 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $209,406 | -7.7% | 27,302 | 0.0% | 0.00% | +50.0% |
Q4 2019 | $226,880 | +12.6% | 27,302 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $201,489 | -34.2% | 27,302 | 0.0% | 0.00% | -33.3% |
Q2 2019 | $306,327 | +55.8% | 27,302 | +49.3% | 0.00% | +50.0% |
Q1 2019 | $196,618 | -28.8% | 18,290 | 0.0% | 0.00% | -33.3% |
Q4 2018 | $276,179 | -18.4% | 18,290 | 0.0% | 0.00% | -25.0% |
Q3 2018 | $338,365 | -19.1% | 18,290 | 0.0% | 0.00% | -20.0% |
Q2 2018 | $418,000 | +9.1% | 18,290 | +35.9% | 0.01% | 0.0% |
Q1 2018 | $383,000 | +56.3% | 13,459 | +16.0% | 0.01% | +66.7% |
Q4 2017 | $245,000 | – | 11,599 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 5,576,471 | $36,526,000 | 1.44% |
Altium Capital Management LP | 273,703 | $1,793,000 | 0.67% |
Jackson Creek Investment Advisors LLC | 80,367 | $526,000 | 0.21% |
HARBOURVEST PARTNERS LLC | 79,193 | $519,000 | 0.20% |
XTX MARKETS LLC | 14,169 | $93,000 | 0.19% |
Perceptive Advisors | 2,577,043 | $16,880,000 | 0.18% |
RTW INVESTMENTS, LP | 1,527,352 | $10,004,000 | 0.17% |
Exane Asset Management | 30,568 | $200,220,000 | 0.14% |
Virtus ETF Advisers LLC | 37,343 | $245,000 | 0.10% |
Congress Park Capital LLC | 25,807 | $169,000 | 0.10% |